13382285011

  • English
    • Menu
    JAK Inhibitors

    current location： Home > Medicine > Targeted Therapies > JAK Inhibitors

    Abrocitinib

    Brief description:通用名：阿布昔替尼英文通用名：Abrocitinib商品名：—药物类型：JAK1 抑制剂原研药研发公司：Pfizer给药方式：口服是否为处方药：是

    basic information

    Product model

    vendor nature

    private

    Release time

    2024-02-20

    page views

    Medicine

    FrontNews

    Cancer Degree Express, December 30, 2025
    New research: Big step toward targeted m
    Next-Generation Targeted Therapies Resha
    Recent advancements in RNA-based and tar
    Researchers develop innovative approache
    Product details

    通用名：阿布昔替尼

    英文通用名：Abrocitinib

    商品名：—

    药物类型：JAK1 抑制剂

    原研药研发公司：Pfizer

    给药方式：口服

    是否为处方药：是


    PreviousBaricitinib

    NextNo.

    Online message

    Product Inquiry

    • Your name：

    • Common mailbox：

    • Your unit：

    • Contact number：

    • detailed address：

    • message content：

    inquiry
    Contact
    • Company Name:

      Asian Frontier Pharmaceutical Information Co., Ltd.​

    • Hotline：

      +86 13382285011

    • Company address：

      No. 88, Moumou Industrial Zone, Tianhe District, Guangzhou City, Guangdong Province

    • E-mail address：

      504051920@qq.com

    Code

    Copyright © 2018-2026 Asian Frontier Pharmaceutical Information Co., Ltd.​ All rights reserved  sitemap.xml

    Phone：13382285011